0001680581-17-000002.txt : 20170725 0001680581-17-000002.hdr.sgml : 20170725 20170725092739 ACCESSION NUMBER: 0001680581-17-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170725 DATE AS OF CHANGE: 20170725 EFFECTIVENESS DATE: 20170725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-267612 FILM NUMBER: 17979453 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 700, SUITE B7102 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 700, SUITE B7102 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D/A 1 primary_doc.xml X0708 D/A LIVE 0001680581 Fulcrum Therapeutics, Inc. ONE KENDALL SQUARE BUILDING 700, SUITE B7102 CAMBRIDGE MA MASSACHUSETTS 02139 617-651-8851 DELAWARE None None Corporation true 2015 Robert Gould One Kendall Square Building 700, Suite B7102 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Mark Levin One Kendall Square Building 700, Suite B7102 Cambridge MA MASSACHUSETTS 02139 Director James Geraghty One Kendall Square Building 700, Suite B7102 Cambridge MA MASSACHUSETTS 02139 Director Alan Ezekowitz One Kendall Square Building 700, Suite B7102 Cambridge MA MASSACHUSETTS 02139 Director James Collins One Kendall Square Building 700, Suite B7102 Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b true 0001680581-16-000001 2016-07-18 true true false 0 55000000 29666666 25333334 false 1 0 0 0 false Fulcrum Therapeutics, Inc. /s/ Robert Gould Robert Gould President and Chief Executive Officer 2017-07-25